Information Journal Paper
APA:
Copy. (2018). Alzheimer’ s disease (AD) therapeutics-1: repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality. BIOCHEMICAL PHARMACOLOGY, 158(-), 359-375. SID. https://sid.ir/paper/769934/en
Vancouver:
Copy. Alzheimer’ s disease (AD) therapeutics-1: repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality. BIOCHEMICAL PHARMACOLOGY[Internet]. 2018;158(-):359-375. Available from: https://sid.ir/paper/769934/en
IEEE:
Copy, “Alzheimer’ s disease (AD) therapeutics-1: repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality,” BIOCHEMICAL PHARMACOLOGY, vol. 158, no. -, pp. 359–375, 2018, [Online]. Available: https://sid.ir/paper/769934/en